For research use only. Not for therapeutic Use.
N2-Methyl Alfuzosin(CAT: C000261) is categorized as an impurity of Alfuzosin. Alfuzosin is a medication primarily used to treat benign prostatic hyperplasia (BPH) by relaxing the muscles in the prostate and bladder neck. In pharmaceutical manufacturing, it’s essential to monitor and control the presence of impurities like N2-Methyl Alfuzosin to ensure the purity and safety of the Alfuzosin drug product.
| Catalog Number | C000261 |
| CAS Number | 98902-34-2 |
| Synonyms | (RS)-N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)amino]propyl]tetrahydro-N-methyl-2-furancarboxamide; Alfuzosin EP Impurity C |
| Molecular Formula | C₁₉H₂₇N₅O₄ |
| Purity | ≥95% |
| Solubility | DMSO (Slightly), Methanol (Slightly) |
| Appearance | White to Pale Beige Solid |
| Storage | 4°C, Hygroscopic |
| Reference | Brogden, R.N., et al.: Drugs, 14, 163 (1977), Thien, T., et al.: Lancet, 1, 363 (1977), |
